About this trial
This randomized clinical trial aims to compare the effect of the left lateral decubitus position versus the supine position on the duration of the active phase of labor in nulliparous women. A total of 188 participants will be randomly assigned to one of two groups. The intervention group will be placed in the left lateral decubitus position, while the control group will remain in the supine position. Both positions will be maintained for 30-minute intervals with 5-minute rest periods, continuing until delivery. The primary outcome is the duration of the active phase of labor. Secondary outcomes include rates of cesarean section, use of oxytocin and analgesics, and maternal and neonatal complications.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Signed and dated informed consent form.
Nulliparous woman.
Singleton pregnancy at ≥37 weeks of gestation.
Intact amniotic membranes.
Disqualifiers
Previous uterine surgery.
Maternal condition preventing vaginal delivery.
Fetal anomaly.
Premature rupture of membranes.
Trial design
Parallel
Treatments tested in this trial
Left Lateral Decubitus Group
Other interventionParticipants will be placed in the left lateral decubitus position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.
Supine Position Group
Other interventionParticipants will remain in the supine position for periods of 30 minutes, interspersed with 5-minute rest periods. This cycle will continue throughout the active phase of labor until delivery.
Treatment groups
Trial outcomes
Primary outcomes
Duration of the active phase of labor.
The primary objective is to measure and compare the time taken to progress from the active phase to delivery between the two positioning groups.
Secondary outcomes
Incidence of Cesarean Delivery
The proportion of participants in each group who undergo a cesarean section.
Use of Oxytocin for labor augmentation/conduction.
The proportion of participants in each group who receive oxytocin infusion.
Incidence of maternal complications (e.g., perineal tears, hemorrhage, hypotension).
Composite of adverse maternal outcomes recorded during labor and the immediate postpartum period.
Neonatal status as measured by Apgar score.
The Apgar score (0-10) will be recorded and compared between groups.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.